Molecular pathology of non-small-cell lung cancer

被引:44
作者
Breuer, RHJ [1 ]
Postmus, PE [1 ]
Smit, EF [1 ]
机构
[1] Free Univ Amsterdam, Med Ctr, Dept Pulmonol, NL-1007 MB Amsterdam, Netherlands
关键词
carcinogenesis; lung cancer; molecular pathology; non-small-cell lung cancer; oncogenes; tumor suppressor genes;
D O I
10.1159/000085376
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The molecular basis of lung carcinogenesis must be understood more fully and exploited to enhance survival rates of patients suffering from lung cancer. In this review we will discuss the major molecular alterations that occur in lung cancer. Emphasis is placed on alterations that occur early during carcinogenesis since they might be relevant for future screening programs. Finally we will shortly review new approaches that are used to study the molecular pathology of lung cancer and how they can be applied in a clinical setting. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:313 / 330
页数:18
相关论文
共 205 条
[131]   p53 immunohistochemistry can identify bronchial dysplastic lesions proceeding to lung cancer: a prospective study [J].
Ponticiello, A ;
Barra, E ;
Giani, U ;
Bocchino, M ;
Sanduzzi, A .
EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (03) :547-552
[132]  
RAK J, 1995, CANCER RES, V55, P4575
[133]   Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival [J].
Ratschiller, D ;
Heighway, J ;
Gugger, M ;
Kappeler, A ;
Pirnia, F ;
Schmid, RA ;
Borner, MM ;
Betticher, DC .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) :2085-2093
[134]  
REISSMANN PT, 1993, ONCOGENE, V8, P1913
[135]   Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer [J].
Reissmann, PT ;
Koga, H ;
Figlin, RA ;
Holmes, EC ;
Salmon, DJ .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (02) :61-70
[136]   The expression of β-catenin in non-small-cell lung cancer:: a clinicopathological study [J].
Retera, JMAM ;
Leers, MPG ;
Sulzer, MA ;
Theunissen, PHMH .
JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (12) :891-894
[137]   MUTATIONAL ACTIVATION OF THE K-RAS ONCOGENE - A POSSIBLE PATHOGENETIC FACTOR IN ADENOCARCINOMA OF THE LUNG [J].
RODENHUIS, S ;
VANDEWETERING, ML ;
MOOI, WJ ;
EVERS, SG ;
VANZANDWIJK, N ;
BOS, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (15) :929-935
[138]  
RODENHUIS S, 1988, CANCER RES, V48, P5738
[139]  
Rosell R, 1997, INT J CANCER, V74, P330, DOI 10.1002/(SICI)1097-0215(19970620)74:3<330::AID-IJC17>3.0.CO
[140]  
2-F